Baird Medical Investment Holdings Ltd (BDMD): Shareholders' Equity

Annual figures by period end, from SEC filings.

$31.22M
As of 2025-12-31
+6.6%
3-year compound annual growth
$39.76M2022-12-31: $25.78M2023-12-31: $35.71M2024-12-31: $39.76M2025-12-31: $31.22M$31.22M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$31.22M-21.5%2026-07-27, Balance as of period end
2024-12-31$39.76M+11.4%2026-07-27, Balance as of period end
2023-12-31$35.71M+38.5%2026-07-27, Balance as of period end
2022-12-31$25.78Mn/a2025-05-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$31.22M-21.5%
DarioHealth Corp. (DRIO)2025-12-31$67.92M-5.7%
Spectral AI, Inc. (MDAI)2025-12-31-$5.73Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$3.10M-29.8%
Nephros Inc (NEPH)2025-12-31$10.20M+18.8%
Sensus Healthcare, Inc. (SRTS)2025-12-31$48.10M-13.8%
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$1.49Mn/m
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m

Compare BDMD, DRIO, MDAI, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗